Lee J - Search Results

1

Impact of erythropoiesis-stimulating agents on red blood cell transfusion in Korea.

Kang RY, Lee J, Lee YH, Lee HS, Jeong JH, Lee YJ. Kang RY, et al. Among authors: lee hs, lee j, lee yh, lee yj. Int J Clin Pharm. 2012 Aug;34(4):651-7. doi: 10.1007/s11096-012-9660-0. Epub 2012 Jun 23. Int J Clin Pharm. 2012. PMID: 22729393

2

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation.

Lee JY, Kim YH, Yi NJ, Kim HS, Lee HS, Lee BK, Kim H, Choi YR, Hong G, Lee KW, Suh KS. Lee JY, et al. Clin Mol Hepatol. 2014 Jun;20(2):192-203. doi: 10.3350/cmh.2014.20.2.192. Epub 2014 Jun 30. Clin Mol Hepatol. 2014. PMID: 25032186 Free PMC article.

3

Awareness of the adverse effects associated with prophylactic corticosteroid use during docetaxel therapy.

Yoo KE, Kang RY, Lee JY, Lee YJ, Suh SY, Kim KS, Kim HS, Lee SH, Lee BK. Yoo KE, et al. Support Care Cancer. 2015 Jul;23(7):1969-77. doi: 10.1007/s00520-014-2547-y. Epub 2014 Dec 13. Support Care Cancer. 2015. PMID: 25500718

4

Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.

Han JM, Ah YM, Suh SY, Jung SH, Hahn HJ, Im SA, Lee JY. Han JM, et al. Int J Clin Pharm. 2016 Oct;38(5):1124-32. doi: 10.1007/s11096-016-0339-9. Epub 2016 Jun 30. Int J Clin Pharm. 2016. PMID: 27365091

5

Evaluation of the effects and adverse drug reactions of low-dose dexamethasone premedication with weekly docetaxel.

Kang RY, Yoo KS, Han HJ, Lee JY, Lee SH, Kim DW, Lee YJ. Kang RY, et al. Support Care Cancer. 2017 Feb;25(2):429-437. doi: 10.1007/s00520-016-3420-y. Epub 2016 Sep 30. Support Care Cancer. 2017. PMID: 27687722

6

Assessment of a medication management program targeting hypertension and diabetes patients: Impact on medication adherence.

Jang S, Han E, Kang C, Cho HM, Sohn HS, Lee JY. Jang S, et al. Res Social Adm Pharm. 2021 Feb;17(2):419-427. doi: 10.1016/j.sapharm.2020.03.002. Epub 2020 Mar 17. Res Social Adm Pharm. 2021. PMID: 32197921

7

Prevalence of anticholinergic burden and risk factors amongst the older population: analysis of insurance claims data of Korean patients.

Jun K, Ah YM, Hwang S, Chung JE, Lee JY. Jun K, et al. Int J Clin Pharm. 2020 Apr;42(2):453-461. doi: 10.1007/s11096-020-01010-7. Epub 2020 Apr 13. Int J Clin Pharm. 2020. PMID: 32281075

8

Underutilization of gastrointestinal prophylaxis in high-risk chronic nonsteroidal anti-inflammatory drug users in Korea.

Kim WY, Lee S, Jun K, Ah YM, Lee JY. Kim WY, et al. Int J Clin Pharm. 2021 Jun;43(3):645-653. doi: 10.1007/s11096-020-01176-0. Epub 2020 Nov 4. Int J Clin Pharm. 2021. PMID: 33147346

9

Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.

Cho YS, Ah YM, Jung AH, Kim KJ, Lee JY. Cho YS, et al. Paediatr Drugs. 2015 Dec;17(6):487-96. doi: 10.1007/s40272-015-0147-z. Paediatr Drugs. 2015. PMID: 26400586

10

Antiepileptic drug adherence and persistence in children with epilepsy attending a large tertiary care children's hospital.

Lee YK, Ah YM, Choi YJ, Cho YS, Kim KJ, Lee JY. Lee YK, et al. Epileptic Disord. 2016 Dec 1;18(4):408-417. doi: 10.1684/epd.2016.0871. Epileptic Disord. 2016. PMID: 27818363 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148,131 results

Search Page

Filters